Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NEOS

Neos Therapeutics (NEOS) Stock Price, News & Analysis

Neos Therapeutics logo

About Neos Therapeutics Stock (NASDAQ:NEOS)

Advanced Chart

Key Stats

Today's Range
$1.06
$1.18
50-Day Range
$0.77
$1.18
52-Week Range
$0.45
$1.68
Volume
15.01 million shs
Average Volume
7.44 million shs
Market Capitalization
$57.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NEOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

NEOS Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
MCET MultiCell Technologies, Inc.
NEOS/USD - NeosCoin US Dollar
Cara Therapeutics, Inc. (CARA)
See More Headlines

NEOS Stock Analysis - Frequently Asked Questions

Neos Therapeutics, Inc. (NASDAQ:NEOS) announced its quarterly earnings results on Monday, November, 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.05. The company earned $12.54 million during the quarter.

Neos Therapeutics (NEOS) raised $60 million in an initial public offering on Thursday, July 23rd 2015. The company issued 4,000,000 shares at $14.00-$16.00 per share. UBS Investment Bank, BMO Capital Markets and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neos Therapeutics investors own include TherapeuticsMD (TXMD), Onconova Therapeutics (ONTX), Adamis Pharmaceuticals (ADMP), Acasti Pharma (ACST), SCYNEXIS (SCYX), Corbus Pharmaceuticals (CRBP) and AVEO Pharmaceuticals (AVEO).

Company Calendar

Last Earnings
11/09/2020
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NEOS
Fax
N/A
Employees
213
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.90 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$64.65 million
Price / Cash Flow
N/A
Book Value
($0.12) per share
Price / Book
-9.58

Miscellaneous

Free Float
N/A
Market Cap
$57.22 million
Optionable
Optionable
Beta
1.50
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:NEOS) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners